Background: Financial protection from the risks of ill health has globally recognized importance as a principal performance goal of any health system. This type of financial protection involves minimizing catastrophic payments for healthcare and their associated impoverishing effects....

This paper presents the first attempt to use a discrete choice experiment to derive distributional weights for quality adjusted life years (QALYs), based on characteristics (age and severity) of the beneficiaries. A novel approach using the Hicksian compensating variation is applied. Advantages...

In this paper, we compare single and joint evaluation (JE) of competing public sector programmes in a contingent valuation exercise. Using survey data aimed at evaluating WTP for cancer interventions (n = 2628), we disantangle two types of effects of JE: informational effects and sequence...

The aim of The Elgar Companion to Health Economics is to take an audience of advanced undergraduates, postgraduates and researchers to the frontier of research in health economics, by providing them with short and easily readable introductions to key topics. The volume brings together 50...

This comprehensive collection brings together more than 50 contributions from some of the most influential researchers in health economics. It authoritatively covers theoretical and empirical issues in health economics, with a balanced range of material on equity and efficiency in health care...

Health systems typically apply cost-utility frameworks in response to the moral dilemma of how best to allocate scarce health care resources. However, implementation of recommendations based on costs and benefit calculations and subsequent challenges have led to 'special cases' which enable the...

In recent years civil society organisations, associations, institutions and groups have become increasingly involved at various levels in the governance of healthcare systems around the world. In the UK, particularly in the context of recent reform of the National Health Service in England,...

<section xml:id="hec3018-sec-0001" numbered="no"> Background</title> The appropriate thresholds for decisions on the cost‐effectiveness of medical interventions remain controversial, especially in ‘end‐of‐life’ situations. Evidence of the values placed on different types of health gain by the general public is limited.</section> <section xml:id="hec3018-sec-0002" numbered="no"> <title type="main">Methods</title> Across nine...</section>